Charles V. Baltic III, Director at MEI Pharma, Inc. (MEIP), bought 3,500 shares at $7.19 ($25K) on 2012-12-21, disclosed to the SEC on 2012-12-26.
Open-market purchase of $25k MEIP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.17 | 1,700 | $12K | 48.5% |
| 2 | $7.19 | 1,800 | $13K | 51.5% |
| Total | $7.18 avg | 3,500 | $25K | 100% |
| Filing → |
| MEIP | SELL | 2017-11-29 | $24K | — | Filing → |
| MEIP | BUY | 2015-01-23 | $19K | — | Filing → |
| MEIP | BUY | 2015-01-02 | $13K | — | Filing → |